You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

Article metrics

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics
PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

 

Online download statistics by month:

Online download statistics by month: September 2022 to August 2023

AbstractFullPdf
Sep 202260010
Oct 2022152020
Nov 2022750021
Dec 20224305
Jan 202310506
Feb 2023131018
Mar 202393013
Apr 2023114012
May 20236404
Jun 20233204
Jul 20234006
Aug 20234004
Total16240123